Talus Bio

Talus Bioscience is a venture-backed, early-stage biotechnology startup company based in Seattle, Washington. The company employs 17 people. Talus Bio specializes in drug development for gene regulators, focusing primarily on small-molecule drug development in oncology. Their platform is designed to measure a drug's ability to disrupt a gene regulator within its natural cellular environment. This platform can simultaneously analyze the activity of approximately 1,000 gene regulators in a single experiment, providing insights into in-cell drug activity and specificity. The company utilizes innovative cell processing, high-sensitivity quantitative proteomics, and advanced analytics to achieve this. Talus Bio is pursuing two main goals: developing internal drug programs targeting previously undruggable gene regulators in cancers with limited treatment options, and partnering with pharmaceutical, biotechnology, and academic laboratories to advance their gene regulator drug pipelines. For more information, visit talus.bio.